Skip to content

Clinical trials

Phase 1 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 1 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20091
20101
20111
20122
20133
20143
20151
20161
20172
20181
20193
20221
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated2
Not yet recruiting2
Withdrawn1
Recruiting1
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis2
PolyActiva Pty Ltd2
Aerpio Therapeutics1
Alcon Research1
Allergan1
Amakem, NV1
Amneal Pharmaceuticals, LLC1
Care Team Solutions1
D. Western Therapeutics Institute, Inc.1
Daniel Moore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension30
Glaucoma15
Glaucoma, Open-Angle15
Eye Diseases3
Disease1
Hydrophthalmos1

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.